Location History:
- Chapel Hill, NC (US) (2020)
- Ithaca, NY (US) (2020 - 2021)
Company Filing History:
4 out of 1,361 
2 out of 8 
Years Active: 2020-2021
Title: Clint A Stalnecker: Innovator in Glutaminase Research
Introduction
Clint A Stalnecker is a notable inventor based in Ithaca, NY (US), recognized for his contributions to the field of glutaminase research. He holds a total of four patents that focus on innovative methods and compounds related to glutaminase proteins.
Latest Patents
Stalnecker's latest patents include significant advancements in labeled glutaminase proteins and isolated glutaminase protein mutants. One of his inventions relates to a labeled glutaminase (GLS) protein that comprises a GLS protein and a fluorescent reporter group attached to it. This fluorescent reporter group is specifically attached within the glutaminase domain pfam04960 of GLS. Additionally, he has developed methods for screening compounds that allosterically bind to glutaminase proteins and for identifying compounds that inhibit or stabilize tetramer formation of these proteins. His work also includes inhibitors of kidney-type glutaminase, GLS-1, which encompasses pharmaceutical compounds and their methods of use.
Career Highlights
Throughout his career, Clint A Stalnecker has worked with esteemed institutions such as Cornell University and Ithaca College. His research has significantly impacted the understanding and application of glutaminase proteins in various fields.
Collaborations
Stalnecker has collaborated with notable colleagues, including Richard A Cerione and Kristin Wilson Cerione, enhancing the scope and depth of his research endeavors.
Conclusion
Clint A Stalnecker's innovative work in glutaminase research has led to valuable patents and collaborations that contribute to advancements in the field. His dedication to scientific exploration continues to influence the development of new therapeutic approaches.